Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$651M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$622M |
| 3 |
Merck
MRK
|
+$496M |
| 4 |
Adobe
ADBE
|
+$446M |
| 5 |
CRH
CRH
|
+$410M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.33B |
| 2 |
Microsoft
MSFT
|
+$965M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$542M |
| 4 |
NVIDIA
NVDA
|
+$522M |
| 5 |
Linde
LIN
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.03% |
| 2 | Technology | 8.55% |
| 3 | Healthcare | 6.96% |
| 4 | Financials | 6.02% |
| 5 | Industrials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
PUT
10x Genomics
TXG
$8.02B
| $1.13M | ﹤0.01% |
30,000
+20,000
| +200% | +$879K |
|
4077
PUT
LivaNova
LIVN
$4.43B
| $1.12M | ﹤0.01% |
20,100
+10,100
| +101% | +$525K |
|
4078
PUT
Steris
STE
$22.8B
| $1.12M | ﹤0.01% |
+5,000
| New | +$1.13M |
|
4079
PUT
Vodafone
VOD
$37.1B
| $1.12M | ﹤0.01% |
+126,200
| New | +$1.1M |
|
4080
Atlanta Braves Holdings Series A
BATRA
$3.58B
| $1.12M | ﹤0.01% |
26,804
+6,942
| +35% | +$293K |
|
4081
Cerence
CRNC
$384M
| $1.12M | ﹤0.01% |
71,195
-397,567
| -85% | -$6.72M |
|
4082
CALL
M&T Bank
MTB
$34.3B
| $1.12M | ﹤0.01% |
7,700
+4,300
| +126% | +$596K |
|
4083
Ceragon Networks
CRNT
$191M
| $1.12M | ﹤0.01% |
348,947
+52,844
| +18% | +$145K |
|
4084
Traeger
COOK
$156M
| $1.12M | ﹤0.01% |
8,823
-2,210
| -20% | -$252K |
|
4085
PMV Pharmaceuticals
PMVP
$65.2M
| $1.11M | ﹤0.01% |
+655,461
| New | +$1.22M |
|
4086
CALL
Lantheus
LNTH
$6.58B
| $1.11M | ﹤0.01% |
17,900
-24,800
| -58% | -$1.46M |
|
4087
CALL
Toll Brothers
TOL
$13.5B
| $1.11M | ﹤0.01% |
8,600
+4,200
| +95% | +$457K |
|
4088
Supernus Pharmaceuticals
SUPN
$2.54B
| $1.11M | ﹤0.01% |
32,589
-141,999
| -81% | -$4.23M |
|
4089
CALL
Darling Ingredients
DAR
$10.1B
| $1.11M | ﹤0.01% |
+23,900
| New | +$1.05M |
|
4090
CALL
Capri Holdings
CPRI
$1.53B
| $1.11M | ﹤0.01% |
+24,500
| New | +$1.17M |
|
4091
Prestige Consumer Healthcare
PBH
$2.49B
| $1.1M | ﹤0.01% |
15,218
-7,672
| -34% | -$513K |
|
4092
Fortis
FTS
$27.9B
| $1.1M | ﹤0.01% |
27,923
+12,431
| +80% | +$495K |
|
|
4093
PUT
Darling Ingredients
DAR
$10.1B
| $1.1M | ﹤0.01% |
+23,700
| New | +$1.04M |
|
4094
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
| $1.1M | ﹤0.01% |
7,445
-42,214
| -85% | -$6.06M |
|
4095
KT
KT
$9.35B
| $1.1M | ﹤0.01% |
78,185
-16,140
| -17% | -$223K |
|
|
GATO
4096
DELISTED
Gatos Silver, Inc.
GATO
| $1.1M | ﹤0.01% |
130,627
-185,848
| -59% | -$1.24M |
|
4097
Pacira BioSciences
PCRX
$1.03B
| $1.09M | ﹤0.01% |
+37,448
| New | +$1.15M |
|
|
COOP
4098
PUT
DELISTED
Mr. Cooper
COOP
| $1.09M | ﹤0.01% |
14,000
-24,000
| -63% | -$1.67M |
|
4099
Triumph Financial Inc
TFIN
$1.72B
| $1.09M | ﹤0.01% |
13,693
+5,112
| +60% | +$386K |
|
4100
US Bancorp
USB
$97.3B
| $1.09M | ﹤0.01% |
24,296
-439,643
| -95% | -$18.6M |
|
Similar funds
Israel Englander's Q1 2024 Portfolio in Review
As of Q1 2024, Israel Englander held 6,887 positions worth $234B, up 1.3% from $231B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Israel Englander's Q1 2024 filing shows 858 new, 2,292 increased, 2,484 reduced and 745 closed positions. Its largest new stake was iShares Bitcoin Trust: 20,859,447 shares worth $844M. The largest sale was iShares Core S&P 500 ETF, an estimated $4.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 59% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q1 2024 buy was iShares Bitcoin Trust: 20,859,447 shares worth $844M.
- Israel Englander added most to Merck in Q1 2024, an estimated $496M increase.
- Israel Englander's biggest Q1 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.33B.
- Israel Englander fully exited Splunk Inc in Q1 2024, selling an estimated $319M.
- Israel Englander's ten largest holdings make up 17% of its $234B portfolio in Q1 2024.
- Israel Englander opened 858 new positions and closed 745 in Q1 2024.
- Israel Englander's portfolio value rose 1.3% quarter-over-quarter to $234B.
Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.